, Tracking Stock Market Picks
Enter Symbol:

up 1,583.45 %

QUESTOR PHARMACEUTCL (QCOR) rated Buy with price target $11 by Stanford Research

Posted on: Tuesday,  Dec 9, 2008  12:25 PM ET by Stanford Research

Stanford Research rated Buy QUESTOR PHARMACEUTCL (NASDAQ: QCOR) on 12/09/2008. Previously Stanford Research rated Buy QUESTOR PHARMACEUTCL (NASDAQ: QCOR) on 09/11/2008.,
when the stock price was $5.56. Since then, QUESTOR PHARMACEUTCL has gained 1583.45% as of 08/14/2014's recent price of $93.60.
If you would have followed the previous Stanford Research's recommendation on QCOR, you would have gained 1583.45% of your investment in 2163 days.

Questcor Pharmaceuticals, Inc. (Questcor) markets H.P. Acthar Gel (repository corticotropin injection), an injectable drug that is approved for the treatment of certain disorders with an inflammatory component, including the treatment of exacerbations associated with multiple sclerosis (MS), and the treatment of nephrotic syndrome. H.P. Acthar Gel (Acthar) is not indicated for, but is also used in treating patients with infantile spasms (IS). The Company also markets Doral (quazepam), which is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. As of December 31, 2008, Acthar was approved in the United States for the treatment of exacerbations associated with MS, nephrotic syndrome and many other conditions with an inflammatory component.

Stanford Research encompasses both institutional equity research and Washington-focused policy research, offering a perspective on individual companies, sector-specific topics and national policy. The importance Stanford Group Company places on research comes from years of experience in a constantly changing world. We know that as markets develop and new sectors grow, it is imperative that our clients have the most accurate information available to ensure financial success. Stanford Group Company clients will always have our commitment to conduct informative and enlightening research. As a part of our commitment to our clients, we provide objective, well-developed research. Our skilled analysts use their talent to provide invaluable research that can help in making important decisions. Thanks to a wide range of resources obtained through technology, experience and reputation, our research analysts develop reports on the most current firms and sectors. Our equity analysts offer insight and opinions on companies in the consumer/retail, media, energy, financial institutions, health care, technology and water/environment sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/9/2008 12:25 PM Buy
9.58 11.00
as of 12/24/2008
1 Week down  -14.95 %
1 Month up  0.44 %
3 Months down  -30.32 %
1 YTD down  -51.12 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/11/2008 8:25 AM Buy
5.56 7.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy